Active ingredientLaquinimodCat. No. P-L018-001CAS 248281-84-7Family · Pharmaceutical analytical standards
Laquinimod
A tablet immunomodulator studied in large clinical trials for multiple sclerosis. In 2014 the European Medicines Agency confirmed its refusal of authorisation, and development for this disease was later stopped. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Its multiple sclerosis trials had musical names: ALLEGRO, BRAVO, CONCERTO and ARPEGGIO, the last one devoted to the primary progressive form.
Go to the active ingredient →Active ingredientLaquinimodCat. No. P-L018-001CAS 248281-84-7
Active ingredientLaquinimod Sodium SaltCat. No. P-L018-002CAS 248282-07-7
Isotopically labelledLaquinimod-d5Cat. No. P-L018-003CAS 1214267-09-0
Isotopically labelledLaquinimod-d5 Sodium SaltCat. No. P-L018-004CAS 1354744-14-1
ImpurityPaquinimodCat. No. P-L018-005CAS 248282-01-1
ImpurityTasquinimodCat. No. P-L018-006CAS 254964-60-8No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.